China's MicroPort CardioFlow Medtech shines in Hong Kong debut

MicroPort CardioFlow Medtech

04/02/2021 03:46

** Shares of China's medical device developer MicroPort
CardioFlow Medtech Corp  2160.HK  trade as high as at HK$22.20
per share in Hong Kong trading debut, up 82% from their IPO
price 
    ** Stock last up 54.4% from the IPO price of HK$12.20
apiece; fifth most actively traded shares by turnover in late
morning 
    ** Developer of transcatheter and surgical solutions for
valvular heart diseases sold 205.62 mln shares in IPO, raising
HK$2.51 bln ($323.8 mln)  urn:newsml:reuters.com:*:nFWN2K81HD
    ** Shanghai-based unit of MicroPort Scientific Corp
 0853.HK  will use the proceeds for R&D, clinical trial,
post-marketing clinical study, to expand portfolio and
production capacity 
    ** Shares of MicroPort Scientific, however, fall as much as
6.3% to HK$51.75, their lowest since Jan. 19
    ** The Hong Kong Hang Seng Commerce & Industry Index  .HSNC 
falls 1.9%
    ** The Hang Seng China enterprises index  .HSCE  slips 1.2%,
and the benchmark index  .HSI  slides 1.1%


($1 = 7.7514 Hong Kong dollars)

 ((Reuters Messaging:
donny.kwok.thomsonreuters.com@reuters.net))